Didier Raoult

This inventor holds 20 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 23 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université´ D'aix-Marseille, National Institute of Health and Medical Research. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Raoult. Retrieved from https://idiyas.com/inventor/didier-raoult

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 10)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 23 (Patent Applications = 37)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 33(Granted Patents)

Location History:

Marseille, FR (2006 - 2007)
Marseilles, FR (1999 - 2021)

Company Filing History:

10 out of 5,383

Centre National De La Recherche Scientifique

patents

10 out of 237

Université´ D'aix-Marseille

patents

4 out of 1,853

National Institute of Health and Medical Research

patents

4. 3 out of 18

Assistance Publique Hopitaux De Marseille

Fondation Mediterranee Infection

patents

7. 2 out of 2

Fondation Mediterranee Infection Faculté De Médecine

patents

8. 2 out of 2

Protisvalor Mediterranee

patents

9. 1 out of 222

Galderma Research & Development

patents

10. 1 out of 1,380

Hitachi High-Tech Corporation

patents

11. 1 out of 1

Ihu Mediterranee Infection

patent

12. 1 out of 8

Université De La Méditerranée

patents

13. 1 out of 10

Université De La Méditerranée - Aix-Marseille Ii

patents

14. 1 out of 1

Universite De La Mediterranee (Aix-Marsille Ii)

patent

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698519 - Chemical susceptibility inspection method (2026-08-04),

2. 11091735 - Polyvalent culture medium for anaerobic bacteria under aerobic conditions (2021-08-17),

3. 10837044 - Automated method for analyzing and interpreting an antimicrobial susceptibility (2020-11-17),

4. 10626421 - Use of uric acid for culturing bacteria sensitive to oxygen tension (2020-04-21),

5. 10202587 - Vulcanisaetal phosphotriesterase-like lactonases (PLL) having enhanced properties and the uses thereof (2019-02-12),

6. 10125400 - Method for the diagnosis of rosacea (2018-11-13),

7. 10072252 - Sulfolobal phosphotriesterase-like (PLL) lactonases activity having enhanced properties and the uses thereof (2018-09-11),

8. 10011852 - Method for producing methane by means of aerobic co-culture of anaerobic micro-organisms (2018-07-03),

9. 9700051 - Use of squalamine or analogue as a disinfecting agent (2017-07-11),

10. 9493769 - Yeast-based assay for measuring the functional activity of an HIV-1 protease in response to an antiviral agent (2016-11-15),

11. 8841087 - Mycobacteria culture medium and method including mycobacteria of mycobacterium tuberculosis complex (2014-09-23),

12. 8440808 - [object Object] (2013-05-14),

13. 8378078 - Diagnosis of Whipple's disease (2013-02-19),

14. 7989161 - Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system (2011-08-02),

15. 7883870 - [object Object] (2011-02-08),

Title: The Innovative Journey of Inventor Didier Raoult

Introduction: Didier Raoult, a renowned male inventor hailing from Marseilles, France, has made significant contributions to the field of science and innovation.

Latest Patents: Didier Raoult holds several patents in the medical and biotechnology sectors, focusing on novel diagnostic tools and treatment methods for infectious diseases.

Career Highlights: With a distinguished career in microbiology and infectious diseases, Raoult is known for his groundbreaking research in areas such as emerging viruses, antibiotic resistance, and innovative therapeutic approaches.

Collaborations: Throughout his career, Didier Raoult has collaborated with leading scientists, research institutions, and pharmaceutical companies worldwide to advance the frontiers of medical innovation and improve global healthcare outcomes.

Conclusion: In conclusion, Didier Raoult's pioneering work as an inventor and researcher continues to have a profound impact on the field of microbiology, shaping the future of healthcare and inspiring the next generation of innovators.

Profile summary based on public USPTO records.